Clinical Trial: A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations

U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647107) titled 'A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations' on June 09.

Brief Summary: A Phase I, Double-Blind, Randomized, Placebo Controlled Trial to Evaluate Safety and Immunogenicity of Lipovaxin Tuberculosis Vaccine (Bio Farma) in Healthy Populations Aged 18-40 Years in Indonesia

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Tuberculosis TB Infection

Intervention: BIOLOGICAL: LipovaxinS4-EAH (Middle Dose)

0,5 mL of Middle Dose LipovaxinS4-EAH. Administered twice, 28 days apart

BIOLOGICAL: LipovaksinS4-EAH (High Dose)

0,5 mL of HIgh Dose LipovaxinS4-EAH. Administered twice, 28 da...